Colgate-Palmolive Company $CL Shares Acquired by Hamel Associates Inc.

Hamel Associates Inc. boosted its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 524.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 29,281 shares of the company’s stock after purchasing an additional 24,591 shares during the period. Hamel Associates Inc.’s holdings in Colgate-Palmolive were worth $2,498,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cooper Financial Group raised its stake in shares of Colgate-Palmolive by 4.0% during the second quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock worth $270,000 after acquiring an additional 114 shares in the last quarter. Gould Capital LLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock valued at $35,000 after purchasing an additional 115 shares in the last quarter. Redhawk Wealth Advisors Inc. grew its holdings in shares of Colgate-Palmolive by 2.8% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock valued at $397,000 after purchasing an additional 118 shares during the last quarter. SVB Wealth LLC grew its holdings in shares of Colgate-Palmolive by 1.4% during the 2nd quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after purchasing an additional 119 shares during the last quarter. Finally, Sowell Financial Services LLC raised its position in Colgate-Palmolive by 2.1% in the 3rd quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock worth $490,000 after purchasing an additional 119 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John Hazlin sold 23,376 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total transaction of $2,317,730.40. Following the completion of the transaction, the insider directly owned 27,021 shares in the company, valued at approximately $2,679,132.15. This trade represents a 46.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 19,938 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total value of $1,968,678.12. Following the completion of the sale, the chief operating officer directly owned 9,111 shares in the company, valued at approximately $899,620.14. This represents a 68.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 77,414 shares of company stock worth $7,613,786 over the last three months. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Stock Down 0.1%

CL stock opened at $99.62 on Monday. Colgate-Palmolive Company has a fifty-two week low of $75.96 and a fifty-two week high of $101.18. The business’s 50 day moving average price is $90.94 and its two-hundred day moving average price is $90.29. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. The company has a market capitalization of $79.19 billion, a price-to-earnings ratio of 39.07, a price-to-earnings-growth ratio of 4.51 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The business’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.91 EPS. As a group, analysts forecast that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were paid a dividend of $0.53 per share. The ex-dividend date of this dividend was Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 83.14%.

Key Stories Impacting Colgate-Palmolive

These are some of the CL stories that stood out recently:

  • Neutral Sentiment: The analyst revisions were not uniformly positive: Zacks also lowered several quarterly estimates, including Q1 and Q2 FY2027 and Q1 and Q2 FY2028, while increasing others. The overall picture is therefore mixed rather than a broad-based upgrade. Zacks Research forecast coverage
  • Neutral Sentiment: A comparison with Kimberly-Clark highlighted Colgate-Palmolive’s leading global oral-care position and its pet-nutrition business as potential growth diversifiers, but the article did not report a new company-specific catalyst. Colgate-Palmolive vs. Kimberly-Clark
  • Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company shares. Insider sales can weigh on sentiment, although a single transaction does not necessarily indicate a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells Stock

Analysts Set New Price Targets

Several analysts have weighed in on CL shares. BNP Paribas Exane reissued an “outperform” rating and issued a $108.00 price target (up from $97.00) on shares of Colgate-Palmolive in a research note on Monday, November 2nd. Deutsche Bank reaffirmed a “buy” rating and set a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Evercore upped their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research report on Thursday, October 8th. Finally, UBS Group upped their price objective on shares of Colgate-Palmolive from $106.00 to $112.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Thirteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $101.22.

Read Our Latest Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.